Kamada (NASDAQ:KMDA) is scheduled to announce Q1 earnings results on Wednesday, May 14th, before market open. The consensus EPS Estimate is $0.07 (+75.0% Y/Y) and the consensus Revenue Estimate is ...

Over the past three months, shares of Kamada Inc. (NASDAQ: KMDA) increased by 67.51%. Before having a look at the importance of debt, let's look at how much debt Kamada has.Kamada's Debt According ...

Milan have a verbal agreement with Daichi Kamada for the Eintracht Frankfurt midfielder to join the club on a free transfer this summer. The 26-year-old had also attracted interest from Liverpool ...

Kamada Ltd. shares dropped 4.4% in premarket trade Monday on news that the company has not been able to resolve the Food and Drug Administration's concerns about the safety of its therapy, which ...

Amir London, CEO of Kamada Pharmaceuticals, was recently a guest on Benzinga's All-Access. Kamada is a global biopharmaceutical company with a portfolio of assets indicated for rare and serious ...

REHOVOT, Israel (AP) — Kamada Ltd. (KMDA) on Wednesday reported third-quarter earnings of $3.9 million. The Rehovot, Israel-based company said it had net income of 7 cents per share. The results ...

But where South Korea have quality -- and an undeniably top-grade one at that -- Japan can more than make up for it with quantity. Kamada's move to Palace takes Japan's Premier League contingent ...

Crystal Palace have begun an investigation into allegations that midfielder Daichi Kamada was racially abused by supporters at Selhurst Park. The incident is alleged to have taken place after ...

Kamada, like a number of his team-mates in yellow, saw his influence wane as the contest wore on, with Palace players visibly tired. On 70 minutes, he was replaced by Jordan Ayew.

Kamada is a global biopharmaceutical company with a portfolio of assets indicated for rare and serious conditions. The company reports it is a leader in the specialty plasma-derived field, ...